Impax Asset Management Group »

Travere Therapeutics shares owned by Impax Asset Management Group

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Impax Asset Management Group from 13F filings

Historical chart of Impax Asset Management Group investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Impax Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Impax Asset Management Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 475k 23.90
2025-06-30 $7.0M 475k 14.80
2025-03-31 $5.4M 300k 17.92
2024-12-31 $5.2M 300k 17.42

More positions owned by Impax Asset Management Group

Linde Common Stock (LIN)
Microsoft Corp Common Stock (MSFT)
Xylem Common Stock (XYL)
NVIDIA Corp Common Stock (NVDA)
Veralto Corp Common Stock (VLTO)
Hubbell Common Stock (HUBB)
Pentair Common Stock (PNR)
Aptiv Common Stock (APTV)
Agilent Technologies Common Stock (A)
A O Smith Corp Common Stock (AOS)
Advanced Drainage Systems Common Stock (WMS)
IDEX Corp Common Stock (IEX)
RenaissanceRe Holdings Common Stock (RNR)
Synopsys Common Stock (SNPS)
Marvell Technology Common Stock (MRVL)

View all positions for Impax Asset Management Group

Top funds holding Travere Therapeutics

Henderson Group
BlackRock
Armistice Capital
Vanguard Group
Macquarie Group
Perceptive Advisors
Adage Capital Partners GP
State Street Corporation
FMR
Rock Springs Capital Management
Emerald Advisers
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Deutsche Bank Aktiengesellschaft

View all funds holding Travere Therapeutics